The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees, nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential.

Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW ...

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In work published in Cell, the team showed they could isolate T cells that ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, just long enough to learn how to do bone marrow transplant. Instead, he ...

Making precision oncology more precise. The team analyzed paraffin-embedded meningioma samples from a collection Holland and his colleagues have amassed to build the field’s largest meningioma dataset ...

In just 50 years, Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for its expertise in molecular biology, tumor virology and ...